Literature DB >> 16871600

A targeted protease substrate for a quantitative determination of protease activities in the endolysosomal pathway.

Rainer Fischer1, Daniel Bächle, Mariola Fotin-Mleczek, Günther Jung, Hubert Kalbacher, Roland Brock.   

Abstract

Inside the cell, proteases act in concert in the degradation of proteins and peptides. In order to understand the significance of an individual proteolytic activity within an ensemble of proteases, protocols and probes are required that enable a quantitative determination of the contribution of a protease to the break-down of a given substrate. Here we present a fluorescence resonance energy transfer-based probe and protocols for a quantitative determination of proteolytic activities inside the endolysosomal compartment. A peptide substrate that is readily cleaved by different cathepsins is flanked by fluorescein and tetramethylrhodamine-labeled lysine residues. Efficient endolysosomal targeting of the substrate is achieved by N-terminal elongation with the cell-penetrating peptide nona-arginine. The proteasome inhibitor lactacystin has a small, but significant effect on the break-down of the substrate, thus demonstrating that only a minor fraction of the peptide reaches the cytoplasm in its intact form. Nona-arginine therefore constitutes a highly efficient low-molecular-weight moiety for targeting the endolysosomal compartment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16871600     DOI: 10.1002/cbic.200600209

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  7 in total

Review 1.  Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.

Authors:  Ayman El-Sayed; Shiroh Futaki; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-01-06       Impact factor: 4.009

2.  Imaging lysosomal enzyme activity in live cells using self-quenched substrates.

Authors:  William H Humphries; Christine K Payne
Journal:  Anal Biochem       Date:  2012-03-03       Impact factor: 3.365

3.  Modeling of the endosomolytic activity of HA2-TAT peptides with red blood cells and ghosts.

Authors:  Ya-Jung Lee; Gregory Johnson; Jean-Philippe Pellois
Journal:  Biochemistry       Date:  2010-09-14       Impact factor: 3.162

4.  Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors.

Authors:  Andrea M Zuhl; Charles E Nolan; Michael A Brodney; Sherry Niessen; Kevin Atchison; Christopher Houle; David A Karanian; Claude Ambroise; Jeffrey W Brulet; Elizabeth M Beck; Shawn D Doran; Brian T O'Neill; Christopher W Am Ende; Cheng Chang; Kieran F Geoghegan; Graham M West; Joshua C Judkins; Xinjun Hou; David R Riddell; Douglas S Johnson
Journal:  Nat Commun       Date:  2016-10-11       Impact factor: 14.919

Review 5.  Targeted Intracellular Delivery of Antibodies: The State of the Art.

Authors:  Tatiana A Slastnikova; A V Ulasov; A A Rosenkranz; A S Sobolev
Journal:  Front Pharmacol       Date:  2018-10-24       Impact factor: 5.810

6.  Autophagy and exosomes in the aged retinal pigment epithelium: possible relevance to drusen formation and age-related macular degeneration.

Authors:  Ai Ling Wang; Thomas J Lukas; Ming Yuan; Nga Du; Mark O Tso; Arthur H Neufeld
Journal:  PLoS One       Date:  2009-01-08       Impact factor: 3.240

7.  Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines.

Authors:  Nian-Qiu Shi; Yan Li; Yong Zhang; Zheng-Qiang Li; Xian-Rong Qi
Journal:  Int J Nanomedicine       Date:  2018-09-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.